胰岛素
胰岛素释放
葡萄糖转运蛋白
体内
糖尿病
膜
纳米载体
材料科学
药物输送
内科学
化学
医学
生物化学
内分泌学
纳米技术
生物
1型糖尿病
生物技术
作者
Chao Wang,Yanqi Ye,Wujin Sun,Jicheng Yu,Jingqiang Wang,David S. Lawrence,John B. Buse,Zhen Gu
标识
DOI:10.1002/adma.201606617
摘要
Glucose-responsive delivery of insulin mimicking the function of pancreatic β-cells to achieve meticulous control of blood glucose (BG) would revolutionize diabetes care. Here the authors report the development of a new glucose-responsive insulin delivery system based on the potential interaction between the glucose derivative-modified insulin (Glc-Insulin) and glucose transporters on erythrocytes (or red blood cells, RBCs) membrane. After being conjugated with the glucosamine, insulin can efficiently bind to RBC membranes. The binding is reversible in the setting of hyperglycemia, resulting in fast release of insulin and subsequent drop of BG level in vivo. The delivery vehicle can be further simplified utilizing injectable polymeric nanocarriers coated with RBC membrane and loaded with Glc-Insulin. The described work is the first demonstration of utilizing RBC membrane to achieve smart insulin delivery with fast responsiveness.
科研通智能强力驱动
Strongly Powered by AbleSci AI